Brookline Capital Management Stock Recommendations and Price Targets

This is a list of recent ratings by Brookline Capital Management.

DateCompany NameActionCurrent
Price
Price
Target
RatingImpact on
Share Price
9/6/2023
PROC
Procaps Group
Downgrade$4.00 $4.50Buy ➝ HoldLow
8/30/2023
OTLK
Outlook Therapeutics
Downgrade$0.00Buy ➝ HoldLow
8/14/2023
ATBPF
Antibe Therapeutics
Reiterated Rating$0.00BuyLow
8/11/2023
BCEL
Atreca
Downgrade$0.00Buy ➝ HoldLow
6/15/2023
NOVN
Novan
Downgrade$0.00Buy ➝ HoldLow
6/5/2023
BLPH
Bellerophon Therapeutics
Downgrade$0.00Buy ➝ HoldLow
5/25/2023
NMTR
9 Meters Biopharma
Downgrade$0.00Buy ➝ HoldN/A
4/3/2023
ONCT
Oncternal Therapeutics
Downgrade$0.00Buy ➝ HoldLow
3/22/2023
NMTR
9 Meters Biopharma
Reiterated Rating$0.00BuyLow
3/10/2023
APGN
Apexigen
Downgrade$0.00Buy ➝ HoldLow
3/9/2023
ONCT
Oncternal Therapeutics
Reiterated Rating$0.00BuyLow
2/14/2023
DARE
Daré Bioscience
Reiterated Rating$0.00BuyLow
2/13/2023
FUSN
Fusion Pharmaceuticals
Reiterated Rating$3.00BuyLow
1/31/2023
HEPA
Hepion Pharmaceuticals
Reiterated Rating$5.00BuyLow
1/20/2023
BCEL
Atreca
Reiterated Rating$0.00BuyLow
1/12/2023
ECOR
electroCore
Reiterated Rating$5.00BuyN/A
1/6/2023
BIOC
Biocept
Downgrade$1.00Buy ➝ HoldLow
12/12/2022
APGN
Apexigen
Reiterated Rating$0.00BuyLow
12/7/2022
CWBR
CohBar
Downgrade$3.00Buy ➝ HoldLow
11/14/2022
IMNN
Imunon
Reiterated Rating$1.00BuyLow
10/25/2022
NMTR
9 Meters Biopharma
Reiterated Rating$0.00BuyLow
10/3/2022
NMTR
9 Meters Biopharma
Reiterated Rating$0.00BuyLow
10/3/2022
ADIL
Adial Pharmaceuticals
Reiterated Rating$3.00BuyLow
10/3/2022
DRMA
Dermata Therapeutics
Reiterated Rating$1.00BuyLow
10/3/2022
BIOC
Biocept
Reiterated Rating$1.00BuyLow
10/3/2022
EDSA
Edesa Biotech
Reiterated Rating$1.00BuyLow
10/3/2022
OTLK
Outlook Therapeutics
Reiterated Rating$0.00BuyLow
10/3/2022
CYCC
Cyclacel Pharmaceuticals
Reiterated Rating$0.00BuyLow
10/3/2022
MNPR
Monopar Therapeutics
Reiterated Rating$1.00BuyLow
10/3/2022
IMNN
Imunon
Reiterated Rating$1.00BuyLow
10/3/2022
VXRT
Vaxart
Reiterated Rating$1.00BuyLow
10/3/2022
CWBR
CohBar
Reiterated Rating$3.00BuyLow
10/3/2022
LSTA
Lisata Therapeutics
Reiterated Rating$2.00BuyLow
8/15/2022
ATE
Antibe Therapeutics
Reiterated RatingC$0.00BuyN/A
8/10/2022
ARCT
Arcturus Therapeutics
Reiterated Rating$27.00BuyLow
8/8/2022
BCEL
Atreca
Reiterated Rating$0.00BuyLow
6/30/2022
ATBPF
Antibe Therapeutics
Reiterated Rating$0.00BuyN/A
5/18/2022
VERU
Veru
Boost Price Target$1.00$29.00 ➝ $31.00Buy ➝ BuyMedium
4/4/2022
BLPH
Bellerophon Therapeutics
Lower Price Target$0.00$26.00 ➝ $19.00Low
3/10/2022
VRCA
Verrica Pharmaceuticals
Reiterated Rating$4.00BuyMedium
3/7/2022
NTLA
Intellia Therapeutics
Upgrade$32.00 $91.00Hold ➝ BuyHigh
2/14/2022
CRBU
Caribou Biosciences
Reiterated Rating$5.00BuyMedium
2/14/2022
CRSP
CRISPR Therapeutics
Reiterated Rating$45.00 $143.00BuyHigh
2/14/2022
NTLA
Intellia Therapeutics
Reiterated Rating$32.00BuyLow
2/3/2022
BCDA
BioCardia
Reiterated Rating$0.00BuyHigh
2/2/2022
FUSN
Fusion Pharmaceuticals
Reiterated Rating$3.00BuyMedium
2/1/2022
ICCM
IceCure Medical
Reiterated Rating$1.00BuyLow
1/26/2022
HEPA
Hepion Pharmaceuticals
Reiterated Rating$5.00BuyLow
1/19/2022
DARE
Daré Bioscience
Reiterated Rating$0.00BuyHigh
12/14/2021
PROC
Procaps Group
Reiterated Rating$4.00 $13.00BuyLow
12/1/2021
PNT
POINT Biopharma Global
Reiterated Rating$7.00 $23.00BuyMedium
10/19/2021
NOVN
Novan
Reiterated Rating$0.00 $16.00BuyMedium
10/13/2021
KYMR
Kymera Therapeutics
Reiterated Rating$18.00 $80.00BuyMedium
10/13/2021
ADIL
Adial Pharmaceuticals
Reiterated Rating$3.00 $300.00BuyHigh
10/8/2021
BIOC
Biocept
Reiterated Rating$1.00BuyMedium
9/21/2021
DRMA
Dermata Therapeutics
Reiterated Rating$1.00 $224.00BuyHigh
9/3/2021
FBRX
Forte Biosciences
Reiterated Rating$1.00HoldLow
8/27/2021
VERU
Veru
Reiterated Rating$1.00BuyMedium
8/24/2021
SCYX
SCYNEXIS
Reiterated Rating$3.00BuyLow
7/29/2021
BCEL
Atreca
Reiterated Rating$0.00BuyHigh
6/25/2021
CCCC
C4 Therapeutics
Reiterated Rating$2.00BuyHigh
6/23/2021
BLPH
Bellerophon Therapeutics
Reiterated Rating$0.00BuyMedium
6/3/2021
ATBPF
Antibe Therapeutics
Reiterated Rating$0.00BuyMedium
6/3/2021
ATE
Antibe Therapeutics
Reiterated RatingC$0.00BuyN/A
5/25/2021
MNPR
Monopar Therapeutics
Reiterated Rating$1.00BuyMedium
5/7/2021
BIOX
Bioceres Crop Solutions
Reiterated Rating$11.00BuyN/A
3/30/2021
ONCT
Oncternal Therapeutics
Reiterated Rating$0.00 $16.00BuyHigh
3/30/2021
SQZ
SQZ Biotechnologies
Reiterated Rating$0.00BuyN/A
3/25/2021
NMTR
9 Meters Biopharma
Reiterated Rating$0.00BuyHigh
3/12/2021
NLSP
NLS Pharmaceutics
Initiated Coverage$1.00 $12.00BuyHigh
2/26/2021
MRNA
Moderna
Boost Price Target$100.00$180.00 ➝ $205.00BuyLow
2/2/2021
CNSP
CNS Pharmaceuticals
Initiated Coverage$1.00 $300.00BuyLow
12/17/2020
XFOR
X4 Pharmaceuticals
Initiated Coverage$1.00 $21.00BuyHigh
12/14/2020
VERU
Veru
Boost Price Target$1.00$13.00 ➝ $17.00High
11/10/2020
SYRS
Syros Pharmaceuticals
Initiated Coverage$4.00 $190.00BuyLow
10/23/2020
ECOR
electroCore
Initiated Coverage$5.00 $75.00BuyLow
10/14/2020
AWH
Aspira Women's Health
Reiterated Rating$5.00BuyHigh
10/12/2020
MEIP
MEI Pharma
Reiterated Rating$8.00BuyMedium